Here, serum GKN1 concentrations were examined in patients with HCC, CRC, NSCLC, BRC, PAC, OVC, and PRC to further confirm the potential diagnostic utility of serum GKN1 concentrations in differentiating healthy individuals from patients with non‐gastric cancers. Here, GKN1 is linked to hepatocellular carcinoma.